Wednesday, April 04, 2012 2:30:02 AM
The Swiss pharmaceuticals company again appealed directly to Illumina shareholders to accept its bid after the U.S. company's board rejected the offer ahead of its April 18 shareholder meeting.
"Roche's increased offer represents a significant premium to where Illumina would likely trade on a standalone basis and provides certainty of value through an all-cash payment to Illumina's shareholders," Roche said in the letter.
The two firms have been at odds to win over shareholders. A source close to the situation said top Illumina shareholder Capital Research, which owns 11.4 percent of the company according to Thomson Reuters data, had pressured the board to engage with the Swiss drugmaker after Roche's improved bid.
http://www.reuters.com/article/2012/04/04/illumina-roche-idUSL6E8F40OW20120404?feedType=RSS&feedName=marketsNews&rpc=72
777
Recent ILMN News
- Illumina publicly files Form 10 registration statement ahead of planned divestiture of GRAIL • PR Newswire (US) • 05/06/2024 10:28:00 PM
- Illumina To Webcast Upcoming Investor Conference • PR Newswire (US) • 05/03/2024 01:25:00 PM
- Illumina Reports Financial Results for First Quarter of Fiscal Year 2024 • PR Newswire (US) • 05/02/2024 08:05:00 PM
- Illumina's planned divestment of GRAIL approved by the European Commission • PR Newswire (US) • 04/12/2024 01:00:00 PM
- Delta Generates US$37 Million Profit in Q1, Google and Intel Unveil Cutting-Edge AI Chips, and More News • IH Market News • 04/10/2024 11:13:48 AM
- Illumina appoints Ankur Dhingra Chief Financial Officer, Jakob Wedel Chief Strategy and Corporate Development Officer • PR Newswire (US) • 04/09/2024 08:05:00 PM
- Illumina to Announce First Quarter 2024 Financial Results on Thursday, May 2, 2024 • PR Newswire (US) • 04/04/2024 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 10:47:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 10:37:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 10:35:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 10:34:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 10:33:16 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 10:32:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 10:29:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 10:28:12 PM
- U.S. Stocks May Lack Direction Following Yesterday’s Modest Pullback • IH Market News • 02/27/2024 02:14:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/26/2024 01:57:29 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/16/2024 09:21:12 PM
- Cloudflare Skyrockets 26% Pre-Market; Expedia Plunges 14% After CEO Resignation, and More • IH Market News • 02/09/2024 10:51:57 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:13:11 PM
- Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2023 • PR Newswire (US) • 02/08/2024 09:05:00 PM
- U.S. Index Futures Dip Slightly, Oil Prices Climb • IH Market News • 02/08/2024 10:56:39 AM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/25/2024 09:59:24 PM
- Walt Disney Nominates 12 to Board of Directors, Says CEO Iger's Compensation Doubled in 2023 • Dow Jones News • 01/16/2024 11:18:00 PM
- Concentric by Ginkgo and Illumina collaborate to deploy biosurveillance technologies around the world • PR Newswire (US) • 01/15/2024 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM